Trials / Sponsors / Ankyra Therapeutics, Inc
Ankyra Therapeutics, Inc
Industry · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Car Cutaneous Squamous Cell Carcinoma (CSCC), Renal Transplant, Solid Tumor | Phase 1 | 2025-12-15 |
| Recruiting | A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Adv Non Small Cell Lung Cancer | Phase 1 | 2025-10-22 |
| Recruiting | Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors Advanced Solid Tumor, Cutaneous Tumor, Subcutaneous Tumor | Phase 1 | 2024-01-19 |